Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ genetics
Cell Proliferation
/ genetics
Cohort Studies
Colorectal Neoplasms
/ genetics
Disease Progression
Down-Regulation
/ genetics
Epithelial-Mesenchymal Transition
/ genetics
Female
Gene Expression Regulation, Neoplastic
/ genetics
Homeodomain Proteins
/ genetics
Humans
Liver
/ pathology
Liver Neoplasms
/ genetics
Male
Middle Aged
Mutation
/ genetics
Neoplasm Metastasis
/ genetics
Up-Regulation
/ genetics
HOX
HOXB9
colorectal cancer
colorectal liver metastases
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Feb 2022
18 Feb 2022
Historique:
received:
28
12
2021
revised:
06
02
2022
accepted:
16
02
2022
entrez:
26
2
2022
pubmed:
27
2
2022
medline:
22
3
2022
Statut:
epublish
Résumé
As is known, HOXB9 is an important factor affecting disease progression and overall survival (OS) in cancer. However, its role in colorectal cancer (CRC) remains unclear. We aimed to explore the role of HOXB9 in CRC progression and its association with OS in colorectal liver metastases (CRLM). We analysed differential
Identifiants
pubmed: 35216396
pii: ijms23042281
doi: 10.3390/ijms23042281
pmc: PMC8879839
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
HOXB9 protein, human
0
Homeodomain Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bright Cancer care charity
ID : 6516036
Références
Ann Surg. 2018 Jun;267(6):1047-1055
pubmed: 29189379
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Cancer Lett. 2018 Jul 10;426:63-72
pubmed: 29654889
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
World J Gastroenterol. 2014 Apr 14;20(14):3719-37
pubmed: 24744570
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Cancers (Basel). 2020 Dec 22;13(1):
pubmed: 33375038
PLoS One. 2018 Oct 15;13(10):e0205837
pubmed: 30321230
PLoS Med. 2012;9(5):e1001216
pubmed: 22675273
JAMA Surg. 2018 Jul 18;153(7):e180996
pubmed: 29799910
Front Genet. 2019 Apr 30;10:396
pubmed: 31114610
Cancers (Basel). 2020 Nov 08;12(11):
pubmed: 33171691
Biochim Biophys Acta. 2016 Dec;1866(2):300-319
pubmed: 27742530
Int J Oncol. 2013 Feb;42(2):403-10
pubmed: 23229642
Oncogenesis. 2013 Sep 16;2:e71
pubmed: 24042735
Int J Mol Sci. 2021 Dec 14;22(24):
pubmed: 34948228
Cancers (Basel). 2019 Apr 12;11(4):
pubmed: 31013831
Clin Cancer Res. 2017 Aug 1;23(15):4312-4322
pubmed: 28298545
Ann Surg Oncol. 2018 Jun;25(6):1454-1455
pubmed: 29616422
Neoplasia. 2007 Feb;9(2):166-80
pubmed: 17356713
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Genes Dis. 2019 Oct 30;8(2):133-145
pubmed: 33997160
Breast Cancer Res Treat. 2009 Jul;116(1):131-43
pubmed: 18668363
Cancer Cell. 2019 Apr 15;35(4):559-572.e7
pubmed: 30905761
Nucleic Acids Res. 2016 Dec 15;44(22):10662-10675
pubmed: 27613418
Br J Cancer. 2014 Aug 26;111(5):883-93
pubmed: 25025961
Tumour Biol. 2020 May;42(5):1010428320918050
pubmed: 32456563
Differentiation. 2003 Oct;71(8):461-76
pubmed: 14641327
Chin J Cancer Res. 2014 Feb;26(1):72-80
pubmed: 24653628
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Dose Response. 2013 Sep 12;12(2):246-58
pubmed: 24910583
Oncogene. 2021 Mar;40(9):1555-1569
pubmed: 33323976
World J Hepatol. 2019 Feb 27;11(2):150-172
pubmed: 30820266
Mol Cancer. 2014 May 05;13:102
pubmed: 24885802
Cell Signal. 2020 Feb;66:109469
pubmed: 31733300
Cells. 2019 Sep 20;8(10):
pubmed: 31547193